Last price paid | 1.39 | |
Change | -5.02% [ -0.07 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 22.04.2024 17:20 |
Fixing | n.a. |
Settlement date | 27.07.2015 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | +25.94% |
Year to date (YTD) | +32.23% |
1 month | +19.74% |
3 months | +28.57% |
1 year | -15.71% |
3 years | +43.08% |
Issue price | 1.06 |
Underlying price on issue | 1.56 |
Premium | 0.00% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH0285906167 |
Symbol | IGBUK |
Security | 28590616 |
Exchange | ZKB |
Currency | CHF |
Expiry | n.a. |
Underlying | GBP/USD Wechselkurs |
Underlying ISIN | GB0031973075 |
Funding level | 1.384570 |
Stop-loss level | 1.372610 |
Distance to stop-loss level | 10.81% |
Long/Short type | Short |
Subscription ratio | 0.10 |
Issuer | Zürcher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 20.07.2015 |
Premium | 0.05% |
Premium p.a. | n.a. |
Leverage | 8.46 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 0.145900 |
Break-even | n.a. |
SSPA value at risk | 16.13% |
SSPA risk rating |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
NOVARTIS N | 90.96 |
Lonza Group | 526.60 |
Partners Group Ho... | 1'207.00 |
ROCHE GS | 229.90 |
Swiss Re | 100.95 |
Name | Price |
---|---|
KUEHNE & NAGEL | 244.80 |
SWISSCOM N | 520.00 |
Givaudan | 3'951.00 |
SONOVA HLDG N | 253.70 |
ZURICH INSURANCE | 452.50 |